Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8604165 | The American Journal of Medicine | 2017 | 26 Pages |
Abstract
cTnI increases are encountered in approximately a third of patients, the majority due to nonatherothrombotic conditions. Compared with patients without myonecrosis, type 2 myocardial infarction and myocardial injury have worse short-term outcomes, with mortality rates >20% at 2 years. hs-cTnI assay does not lead to more myocardial injury or infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Yader MD, Stephen W. MD, Anne MPH, Sarah E. MD, Charles A. MD, Michelle D. MD, Kenneth W. MD, Brian E. MD, Yan PhD, Katherine MD, Benjamin K. MD, Sara A. PhD, Johanna C. MD, Karen DC, Nathaniel L. MD, Fred S. PhD,